Boston Scientific Corp (BSX)

Total asset turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 13,974,000 10,508,000 10,348,000 9,999,000 9,228,000 12,104,000 11,689,000 11,502,000 11,625,000 11,168,000 10,855,000 9,774,000 9,553,000 9,751,000 9,790,000 10,420,000 10,349,000 10,035,000 9,758,000 9,649,000
Total assets US$ in thousands 35,136,000 34,043,000 33,601,000 32,892,000 32,469,000 31,947,000 32,189,000 32,337,000 32,229,000 31,877,000 31,168,000 30,900,000 30,777,000 30,845,000 30,823,000 30,113,000 30,565,000 26,756,000 24,309,000 23,802,000
Total asset turnover 0.40 0.31 0.31 0.30 0.28 0.38 0.36 0.36 0.36 0.35 0.35 0.32 0.31 0.32 0.32 0.35 0.34 0.38 0.40 0.41

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $13,974,000K ÷ $35,136,000K
= 0.40

Total asset turnover measures a company's ability to generate sales revenue from its total assets. In the case of Boston Scientific Corp., the total asset turnover has been relatively stable over the past eight quarters, ranging from 0.38 to 0.41. This indicates that the company is generating approximately $0.40 in sales for every $1 of total assets it owns.

A total asset turnover ratio of 0.40 implies that Boston Scientific Corp. is efficient in utilizing its assets to generate revenue. A higher ratio would indicate that the company is more effective in using its assets to drive sales. Conversely, a lower ratio could suggest that the company may be underutilizing its assets or facing challenges in generating sales.

Overall, the consistent total asset turnover for Boston Scientific Corp. suggests that the company is maintaining a steady level of asset efficiency in generating revenue. However, further analysis in conjunction with other financial ratios and industry benchmarks would provide a more comprehensive assessment of the company's financial performance and asset management effectiveness.


Peer comparison

Dec 31, 2023


See also:

Boston Scientific Corp Total Asset Turnover (Quarterly Data)